Michael Ingegno, MD
Vascular Surgery · San Leandro, CANPI 1447270459
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Cardinal Health 200 LLC at 42.1% of the total. Reporting peaked in 2020 at $3,645 and has fallen 55.6% since, to $1,619 in 2025.
Across 106 payments — averaging $112.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 200 LLC$5K
- Medtronic$3K
- Cordis US CORP.$2K
- Boston Scientific$312
- Mimedx Group, Inc.$168
- Silk Road Medical, Inc.$133
- plus $704 from 16 others
What the payments were for
- Consulting fees$5,70048%
- Travel & lodging$2,04817%
- Food & beverage$4,12535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 200 LLC | 5 | $5,000 |
| Medtronic(2 entities) | 66 | $3,257 |
| Cordis US CORP. | 3 | $2,300 |
| Boston Scientific | 5 | $312 |
| Mimedx Group, Inc. | 3 | $168 |
| Silk Road Medical, Inc. | 1 | $133 |
| Penumbra, Inc. | 1 | $116 |
| W. L. Gore & Associates, Inc. | 1 | $114 |
| Organogenesis Inc. | 2 | $64 |
| Johnson & Johnson | 3 | $61 |
| Venclose Inc. | 1 | $51 |
| Smith+Nephew | 2 | $49 |
| Abbott | 2 | $44 |
| Tactile Systems Technology Inc | 2 | $40 |
| Lemaitre Vascular, Inc. | 2 | $34 |
| Biocompatibles, Inc. | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $23 |
| Terumo Medical Corporation | 1 | $21 |
| Bard Peripheral Vascular, Inc. | 1 | $19 |
| Cook Medical LLC | 1 | $18 |
| Asahi Intecc USA, Inc. | 1 | $15 |
| Surmodics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- S.M.A.R.T. Flex Stent$1,800
- SABER$1,800
- ELITECROSS$700
- IN.PACT Admiral$688
- VenaSeal$501
- ENDURANT IIS$476
- ENROUTE Transcarotid Neuroprotection System$418
- Indigo$231
- Abre$224
- TurboHawk$148
- ELLIPSYS VASCULAR ACCESS SYSTEM$134
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$133
- ENROUTE Transcarotid Stent$133
- HawkOne$125
- GORE TAG Conformable Thoracic Stent Graft$114
How this compares
$11,873 in reported general payments places this provider in the 75th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $35,741 |
| XareltoRivaroxaban | 39 | $32,589 |
| Clobetasol Propionate | 13 | $712 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $292 |
| Cilostazol | 15 | $225 |
| Mupirocin | 33 | $217 |
| ClopidogrelClopidogrel Bisulfate | 27 | $155 |
| Atorvastatin Calcium | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $61 | $32,58939 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 519 vascular surgery providers in California.
Other vascular surgery in San Leandro
- Varinder PhangurehSan Leandro$42K
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.